跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARBOPROST TROMETHAMINE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CARBOPROST TROMETHAMINE INJECTION, USP
Authorized
STANDARD
CARBOPROST TROMETHAMINE INJECTION, USP
dr reddy's laboratories ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4af1415a0a6b40f7
Company
dr reddy's laboratories ltd
Type
Standard
Approval Details
Approval Id
4af1415a0a6b40f7
Drug Approval Canada Name
CARBOPROST TROMETHAMINE INJECTION, USP
Product Name
CARBOPROST TROMETHAMINE INJECTION, USP
Status
Marketed
Status Date
2023-05-16
Original Market Date
2023-05-16
Din
02530430
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
76:00.00
Atc Original
G02AD04 CARBOPROST
Atc Name
g 02 ad 04
Aig Number
0133100001
Company Name
dr reddy's laboratories ltd
Company Address
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090
Active Ingredients
CARBOPROST (CARBOPROST TROMETHAMINE)
250 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4af1415a0a6b40f7
Type
Standard
Back to Health Canada Approvals